Palladium-based nanostructures have attracted the attention of researchers due to their useful catalytic properties and unique ability to form hydrides, which finds application in hydrogen storage and hydrogen detection. Palladium-based nanowires have some inherent advantages over other Pd nanomaterials, combining high surface-to-volume ratio with good thermal and electron transport properties, and exposing high-index crystal facets that can have enhanced catalytic activity. Over the past two decades, both synthesis methods and applications of 1D palladium nanostructures have advanced greatly. In this review, we start by discussing different types of 1D palladium nanostructures before moving on to the different synthesis approaches that can produce them. Next, we discuss factors including kinetic vs. thermodynamic control of growth, oxidative etching, and surface passivation that affect palladium nanowire synthesis. We also review efforts to gain insight into growth mechanisms using different characterization tools. We discuss the effects of concentration of capping agents, reducing agents, metal halides, pH, and sacrificial oxidation on the growth of Pd-based nanowires in solution, from shape control, to yield, to aspect ratio. Various applications of palladium and palladium alloy nanowires are then discussed, including electrocatalysis, hydrogen storage, and sensing of hydrogen and other chemicals. We conclude with a summary and some perspectives on future research directions for this category of nanomaterials.
Cannabidiol (CBD) has been shown to slow cancer cell growth and is toxic to human glioblastoma cell lines. Thus, CBD could be an effective therapeutic for glioblastoma. In the present study, we explored the anticancer effect of cannabidiol loaded magnesium-gallate (CBD/Mg-GA) metal–organic framework (MOF) using the rat glioma brain cancer (C6) cell line. Bioactive and microporous magnesium gallate MOF was employed for simultaneous delivery of two potential anticancer agents (gallic acid and CBD) to the cancer cells. Gallic acid (GA), a polyphenolic compound, is part of the MOF framework, while CBD is loaded within the framework. Slow degradation of CBD/Mg-GA MOF in physiological fluids leads to sustained release of GA and CBD. CBD's anti-cancer actions target mitochondria, inducing their dysfunction and generation of harmful reactive oxygen species (ROS). Anticancer effects of CBD/Mg-GA include a significant increase in ROS production and a reduction in anti-inflammatory responses as reflected by a significant decrease in TNF-α expression levels. Molecular mechanisms that underlie these effects include the modulation of NF-κB expression, triggering the apoptotic cascades of glioma cells. CBD/Mg-GA MOF has potential anti-cancer, anti-inflammatory and anti-oxidant properties. Thus, the present study demonstrates that CBD/Mg-GA MOF may be a promising therapeutic for glioblastoma.